Tag: ICP NK (Natural Killer) Cells

FAQ Blog Series: What’s the Difference between Positive and Negative Immunomagnetic Cell Separation?

The simplicity and speed of immunomagnetic cell separation has made it the go-to method for isolating target cell populations since it was pioneered in 1990 by Miltenyi Biotec. The ability to isolate specific cell types from heterogeneous tissue or blood-derived sources such as whole peripheral blood, bone marrow, or cord blood is critical to advancing […]

Written by on March 14, 2023

Why You Should Start Clinical Grade Cell Supply Discussions Early in Cell and Gene Therapy Development

Cell and gene therapies represent an expanding category of transformative medicines with the potential to change the way we treat human diseases. Broadly, these novel therapies include both in vivo and ex vivo strategies to modify target cells. Ex vivo therapies that involve isolating cells from a patient (autologous) or a donor (allogeneic) and modifying […]

Written by on May 24, 2022

FAQ Series: The Science Behind Cryopreservation

Primary cells, such as those isolated from the bone marrow or peripheral blood, are important for a wide scope of research and clinical applications – from studying molecular mechanisms driving disease progression, to developing ex vivo therapies in regenerative medicine. Unlike immortalized cell lines, primary cells have a finite lifespan in culture and can undergo unwanted changes like genetic drift and […]

Written by on January 11, 2022

Harnessing the Power of Natural Killer Cells for Cancer Immunotherapy

The immune system is our body’s biological defense system against a variety of pathogens and is separated into the innate and adaptive branches. Our innate immune system is the body’s first line of defense, activating immediately or within hours of a foreign antigen’s appearance in the body with natural killer (NK) cells playing a key […]

Written by on April 14, 2021